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Abstract 
SARS-CoV2 infection causes COVID-19,  and represents the most emergent health care crisis of our generation. 
Ample evidence in the scientific literature suggests that SARS-CoV, MERS-CoV, and endemic human corona-
viruses infect brain cells.  We delineate a rationale for encouraging evaluation of the brain, and in particular the 
brainstem, in COVID-19 so that potential neuropathological mechanisms can be delineated. 
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SARS-CoV2 infection causes COVID-19, and repre-
sents the most emergent health care crisis of our gener-
ation. SARS-CoV2 is a member of the betacoronavirus 
family that includes the severe acute respiratory syn-
drome CoV (SARS-CoV) and Middle East respiratory 
syndrome CoV (MERS-CoV), both of which have caused 
fatal infections in the past two decades (Huang et al., 
2020). Although most people recover from the disease, 
SARS-CoV2 can cause severe respiratory distress syn-
drome, particularly in older patients and patients with 
underlying comorbidities (Mahase, 2020). Most of the 
patients who require intensive care ultimately become 
unable to breathe spontaneously (Wang et al., 2020). 
Although SARS-CoV2 shows its effects predominantly on 
the respiratory system, the primary pathophysiology 
behind the respiratory dysfunction and mortality re-
mains elusive. Previous findings of SARS-CoV infection 
and other coronaviruses in the nervous system bring to 
mind the possibility that SARS-CoV2 infection can cause 
respiratory failure by disrupting the cardiorespiratory 
center in the brainstem and are briefly reviewed below. 
It is known that most coronaviruses share similar 
viral structures and infection pathways (Baig et al., 
2020). These structural and pathophysiological similari-
ties between other coronaviruses and SARS-CoV2 likely 
indicate that pathophysiological insights from other 
coronavirus studies may be generalizable to SARS-CoV2. 
SARS-CoV and SARS-CoV2 have high protein homology 
(Baig et al., 2020), and SARS-CoV2 uses the same recep-
tor to enter the host cells with at least 10 times higher 
affinity relative to SARS-CoV (Wrapp et al., 2020). Alt-
hough multiple candidate receptors have been pro-
posed, cellular infection through interaction with the 
Angiotensin (Ang) converting enzyme (ACE2), a trans-
membrane carboxypeptidates sharing homology to 
ACE1’s extracellular domain but with unique transmem-
brane and intracellular domains (Riordan, 2003), seems 
to be critical in the pathogenesis in SARS-CoV (Baig et al., 
2020). Although ACE2 is capable of modifying angioten-
sin I, it catalyzes angiotensin I to Ang- (1-9) rather than 
to Ang II, and plays diverse physiological roles (reviewed 
by (Clarke and Turner, 2012)). ACE2 is expressed in air-
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way epithelia, lung parenchyma, vascular endothelia, 
kidney cells, small intestine cells (Li et al., 2020) and also 
in the brain, particularly in glial cells and neurons (Baig 
et al., 2020). We also note that endemic human CoVs 
have neuroinvasive potential (Desforges et al., 2014). 
With this in mind, several studies have explored the 
extent to which zoonotically transmitted CoVs affect 
human brain function. Studies using different mouse 
lines transgenic for the expression of ACE2 showed ex-
tensive virus replication in the brain, likely mediated 
through retrograde transport through the olfactory bulb. 
Among the brain regions affected by the virus, thalamus, 
cerebrum and brainstem were severely impacted. While 
in the K18-hACE2 transgenic line, the SARS-CoV infection 
induces neuronal death as a result directly from the 
neuronal and not pulmonary infection. An abundant 
neuronal loss was found along with increased inflamma-
tory cytokines, and proliferation of microglia, but not of 
astrocytes (McCray et al., 2007; Netland et al., 2008). 
Additional Studies using transgenic mice demonstrated 
enhanced levels of IL-6, IL-12p40, G-CSF, CXCL1, MIP-a 
and MCP-1 in brain homogenates 3 days after the infec-
tion resulting in an inflammatory cytokine reaction 
(Tseng et al., 2007). Such cytokine elevations and exten-
sive neuronal pathologies in the brainstem were also 
noted in MERS-CoV infections (Li et al., 2016). In this 
same study, the authors showed evidence of viral repli-
cation in primary and porcine astrocytes and human 
glioblastoma and neuroblastoma cell lines (Li et al., 
2016). It is not well established how SARS-CoV infection 
affects astrocytes in vivo and how it mediates the neu-
ronal damage of this syndrome, despite the fact that 
ACE2 is expressed in isolated astrocytes from brainstem, 
cerebellum and medulla (Gallagher et al., 2006; 
Gowrisankar and Clark, 2016). On the other hand, ex-
pression of ACE2 at mRNA and protein levels in neurons 
is also documented. In vivo findings have shown ACE2 
expression in neurons of the paraventricular nucleus 
(PVN), area postrema (AP), dorsal motor nucleus of the 
vagus (DMNV), nucleus of tractus solitarii (NTS), the 
rostroventrolateral medulla (RVLM), and the nucleus 
ambiguous (NA), all brain structures related to cardio-
vascular and respiratory function (Doobay et al., 2007). 
Furthermore, we do not know the extent to which SARS-
CoV affects brains of newborn babies. For instance, a 
timely study emerging from China performed on COVID-
19 outcomes on pediatric patients demonstrated that 
the severity of COVID-19 in children less than 1-year-old 
was very high (53.8% showing critical course) relative to 
other age groups (Dong et al., 2020). Neurological mani-
festations of COVID-19 have also been documented. In a 
preprint study from China, one of 3 patients suffering 
from SARS-CoV2 had neurological manifestations, in-
cluding dizziness, headache, impaired consciousness, 
hypogeusia (reduced ability to taste) and hyposmia (re-
duced ability to smell) (Mao et al., 2020), the latter 
symptoms suggesting neuronal involvement of areas in 
proximity to the olfactory bulb. Another possibility of 
trans-synaptic transfer of SARS-CoV2 is the usage of 
neuroanatomic interconnections of the respiratory and 
gastrointestinal system to nuclei of the brainstem as has 
been noted by the avian influenza virus (Li et al., 2020). 
Finally, SARS-CoV2 could disseminate through the blood 
to the brain via crossing endothelial cells that express 
the ACE2 receptor as another way of transfer (Baig et al., 
2020). 
In conclusion, there is growing evidence that the 
brain could be the main trigger in the severity of COVID-
19, but there is a paucity of evidence derived from hu-
man patients. According to the interim guidance of the 
American Centers for Disease Control (CDC) in March 
2020, CDC recommends collecting swab specimens, 
samples for postmortem microbiologic and infectious 
disease testing, formalin-fixed autopsy tissues from lung, 
upper airway, and other major organs, if an autopsy is 
performed for a confirmed COVID-19 case (Center of 
Disease Control and Prevention, 2020, March 25). How-
ever, additional concerns have also been raised regard-
ing the use of oscillating saws, a tool commonly used 
during brain procurement, as these saws have been 
shown to promote aerosolization. Nevertheless, we 
believe that documenting the extent of CNS involvement 
in severe manifestations, including documenting which 
brainstem nuclei may be affected in the autopsies is 
crucial to clarify the pathophysiology of COVID-19. We 
also recognize that in areas ravaged by the scale of in-
fection and COVID-19 disease, investment in personal 
protective equipment for autopsy would represent an 
unwise decision when front-line workers remain unpro-
tected. We therefore suggest that a coordinated effort 
between health systems work together to meet this 
goal. Drawing inspiration from the neuropathological 
evaluations of brains of HIV infected patients (Petito et 
al., 2003), we suggest that a study design composed of 
20 brains procured from COVID-19 infected decedents 
be performed, with extensive sampling of brainstem 
nuclei to include structures implicated in human control 
of respiration, including the locus coeruleus (Nobuta et 
al., 2015), ventral medulla (Rudzinski and Kapur, 2010), 
and preBotzinger complex (Schwarzacher et al., 2011). It 
would also be important to evaluate COVID19 infected 
decedents without significant neurological manifesta-
tions as potential controls. In this way, highly impactful 
descriptive studies of COVID-19 disease can be achieved 
and the burden of investing in personal protective 
equipment can be shared by various centers. 
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